Pages that link to "Q48279197"

The following pages link to Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination (Q48279197):

Displaying 46 items.

• The role of magnetic resonance in the assessment of multiple sclerosis. (Q30585724) (← links)
• Evaluation of brainstem involvement in multiple sclerosis (Q30596107) (← links)
• Linking structural, metabolic and functional changes in multiple sclerosis. (Q30654880) (← links)
• Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group. (Q30691743) (← links)
• Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature (Q30739162) (← links)
• Early-stage multiple sclerosis : what are the treatment options? (Q30955866) (← links)
• The pros and cons of early treatment of relapsing forms of multiple sclerosis. (Q30960720) (← links)
• Central nervous system atrophy and clinical status in multiple sclerosis (Q33204392) (← links)
• Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells (Q33485522) (← links)
• Aggressive multiple sclerosis: proposed definition and treatment algorithm (Q34478828) (← links)
• Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study (Q34483022) (← links)
• Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI (Q34548774) (← links)
• Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. (Q34582216) (← links)
• Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response (Q34590280) (← links)
• The emerging role of MRI in multiple sclerosis and the new diagnostic criteria (Q34590306) (← links)
• Multiple sclerosis and pregnancy. (Q34788211) (← links)
• Magnetic resonance imaging of multiple sclerosis. (Q34965696) (← links)
• A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis (Q35462222) (← links)
• The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study (Q35470905) (← links)
• Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis (Q35481531) (← links)
• A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting (Q36371640) (← links)
• Neuroradiological evaluation of demyelinating disease (Q36999734) (← links)
• Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis. (Q38322551) (← links)
• Horizontal nystagmus and multiple sclerosis using 3-Tesla magnetic resonance imaging. (Q40338452) (← links)
• Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. (Q40430109) (← links)
• Update on the diagnosis of multiple sclerosis (Q40644011) (← links)
• Volumetric reconstruction from printed films: Enabling 30 year longitudinal analysis in MR neuroimaging. (Q47175352) (← links)
• Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. (Q48199612) (← links)
• Preliminary magnetic resonance study of the macromolecular proton fraction in white matter: a potential marker of myelin? (Q48277264) (← links)
• Brain atrophy at onset and physical disability in multiple sclerosis. (Q48339336) (← links)
• Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis (Q48340179) (← links)
• A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta (Q48438075) (← links)
• Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial (Q48475571) (← links)
• Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study (Q48492541) (← links)
• Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses (Q48647471) (← links)
• Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis (Q48762317) (← links)
• Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. (Q48853337) (← links)
• Prediction of long-term disability in multiple sclerosis (Q48932538) (← links)
• Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. (Q51970002) (← links)
• MRI in predicting conversion to multiple sclerosis within 1 year (Q58802637) (← links)
• Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes (Q60390326) (← links)
• Inflammation and atrophy in multiple sclerosis: MRI associations with disease course (Q74458832) (← links)
• [Are there arguments for initiating an etiological treatment at the onset of the first demyelinating episode?] (Q79793908) (← links)
• Neuroimaging in multiple sclerosis (Q80390223) (← links)
• Evaluation of brainstem involvement in multiple sclerosis (Q87650108) (← links)
• Conversion of clinically isolated syndrome to multiple sclerosis: a prospective multi-center study in Eastern India (Q93003357) (← links)